Korean J Dermatol.
1974 Jun;12(2):33-37.
Clinical Trials of Tavegyl in Dermatologic Field
Abstract
- Clinical trials were done to obtain ifnormation on the clinical efficacy, tolerance and side effects of a new antihistarnine, Mecloprodine(Tavegyl), in various skin disordetrs. A total of 48 patients suffered from various skin disorders as urticaria, eczema etc. v ere treated with 2mg. daily for 3 days to 15 days according to state of disorders. The results are as follows. 1. Improvement was noticed in 79.2% of total patients(38/48). 2. Tavegyl was efiective in all 8 cases of acute urticaria and most cases(7/8) of urticaria factitia. 3. Among 19 cases of chronic urticaria, improvement was noticed in 13 cases(68. 49). Improvement was alsa noticed in all 6 cases of eczema. 5. Drowsiness and weakness cccurred in 6.2% of cases(3/48).
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Correction of International Classification of Disease, for Effective Management of Dermatologic Disease
- Top applications of dermatologic ultrasonography that can modify management
- Transforming clinical trials: the emerging roles of large language models
- Understanding noninferiority trials
- Methodological Review on Cardiovascular Disease Clinical Trials in Korea
